Upload Avatar (500 x 500)
Han Wei
doctorhanwei@hotmail.com
English, Chinese, German
Jiangsu
Nanjing University
Medical School
  • 2019.04—Present - Nanjing University Medical School Affiliated Stomatological Hospital - Chief Physician, Ward Director
  • 2018.12—Present - Nanjing University - Professor
  • 2017.09—Present - Nanjing University - Doctoral Supervisor
  • 2016.06—2016.08 - University of Washington School of Dentistry - Visiting Scholar
  • 2013.12—2014.12 - MD Anderson Cancer Center Head and Neck Surgery - Visiting Scholar
  • 2012.12—2019.03 - Nanjing University Medical School Affiliated Stomatological Hospital - Associate Chief Physician, Oral and Maxillofacial Surgery
  • 2011.07—2014.12 - Nanjing University Medical School Affiliated Stomatological Hospital - Deputy Director, Central Laboratory
  • 2011.06—2011.07 - University of Leeds School of Dentistry - Visiting Scholar
  • 2009.07—2012.12 - Nanjing University Medical School Affiliated Stomatological Hospital - Attending Physician, Oral and Maxillofacial Surgery
  • 2008.06—2008.08 - Ludwig Maximilian University of Munich Medical School - AO Fellow, Oral and Maxillofacial Surgery
  • 2004.07—2008.06 - Nanjing University Medical School Affiliated Stomatological Hospital - Physician, Oral and Maxillofacial Surgery
  • 2021: Jiangsu Province 333 High-Level Talent
  • 2019: Fifth Nanjing Region 'People's Satisfied Health Worker' and 'Top Ten Doctors'
  • 2019: Nanjing May 1st Labor Medal
  • 2017: Jiangsu Province Science and Technology Second Prize
  • 2017: Jiangsu Province Medical New Technology Introduction Second Prize
  • 2017: Nanjing Outstanding Young and Middle-aged Expert
  • 2016: Nanjing Science and Technology Progress Third Prize
  • 2016: Jiangsu Province Young Medical Key Talent
  • 2015: Jiangsu Province Six Talent Peaks High-Level Talent
  • 2015: Nanjing Youth Post Expert
  • 2012: First Qiu Weiliu Young Physician Award
  • 2007: Jiangsu Province Science and Technology Progress Second Prize
Research on nano drug delivery systems targeting the tumor microenvironment
Study on the role mechanism of hypoxic microenvironment in the progression of oral squamous cell carcinoma
  • Multifunctional photodynamic/photothermal nano-agents for the treatment of oral leukoplakia, Lin L, Song C, Wei Z, Zou H, Han S, Cao Z, Zhang X, Zhang G, Ran J, Cai Y, Han W, 2022
  • A novel NIR-II theranostic agent: a win-win strategy of tracing and blocking tumor-associated vessels for oral squamous cell carcinoma, Wei Z, Zhang H, Zou H, Song C, Zhao S, Cao Z, Zhang X, Zhang G, Cai Y, Han W, 2022
  • Novel semiconducting nano-agents incorporating tirapazamine for imaging guided synergistic cancer hypoxia activated photo-chemotherapy, Zhang G, Wang W, Zou H, Wei Z, Song C, Ran J, Cao Z, Cai Y, Han W, 2021
  • Novel NIR-II semiconducting molecule incorporating sorafenib for imaging guided synergetic cancer phototherapy and anti-angiogenic therapy, Zou H, Wei Z, Song C, Ran J, Cao Z, Tang C, Zhang G, Cai Y, Lu M, Han W, 2021
  • Cancer-associated fibroblasts secrete hypoxia-induced serglycin to promote head and neck squamous cell carcinoma tumor cell growth in vitro and in vivo by activating the Wnt/β-catenin pathway, Xie J, Qi X, Wang Y, Yin X, Xu W, Han S, Cai Y, Han W, 2021
  • Peroxidase-mimicking evodiamine/indocyanine green nanoliposomes for multimodal imaging-guided theranostics for oral squamous cell carcinoma, Wei Z, Zou H, Liu G, Song C, Tang C, Chen S, Zhang G, Ran J, Wang Y, Yin X, Cai Y, Han W, 2021
  • Organic Near-Infrared-II Nanophotosensitizer for Safe Cancer Phototheranostics and Improving Immune Microenvironment against Metastatic Tumor, Song C, Ran J, Wei Z, Wang Y, Chen S, Lin L, Zhang G, Cai Y, Han W, 2021
  • Polycyclic naphthalenediimide-based nanoparticles for NIR-II fluorescence imaging guided phototherapy, Tang C, Song C, Wei Z, Liang C, Ran J, Cai Y, Dong X, Han W, 2020
  • Hypoxia-Targeting Multifunctional Nanoparticles for Sensitized Chemotherapy and Phototherapy in Head and Neck Squamous Cell Carcinoma, Song C, Tang C, Xu W, Ran J, Wei Z, Wang Y, Zou H, Cheng W, Cai Y, Han W, 2020
  • Anti-LDLR modified TPZ@Ce6-PEG complexes for tumor hypoxia-targeting chemo-/radio-/photodynamic/photothermal therapy, Song C, Xu W, Wei Z, Ou C, Wu J, Tong J, Cai Y, Dong X, Han W, 2020
  • Metformin enhances gefitinib efficacy by interfering with interactions between tumor-associated macrophages and head and neck squamous cell carcinoma cells, Yin X, Han S, Song C, Zou H, Wei Z, Xu W, Ran J, Tang C, Wang Y, Cai Y, Hu Q, Han W, 2019
  • Carrier-free nano-integrated strategy for synergetic cancer anti-angiogenic therapy and phototherapy, Wei Z, Liang P, Xie J, Song C, Tang C, Wang Y, Yin X, Cai Y, Han W, Dong X, 2019
  • A Novel Multimodal NIR-II Nanoprobe for the Detection of Metastatic Lymph Nodes and Targeting Chemo-Photothermal Therapy in Oral Squamous Cell Carcinoma, Wang Y, Zhang W, Sun P, Cai Y, Xu W, Fan Q, Hu Q, Han W, 2019
  • Optical nano-agents in the second near-infrared window for biomedical applications, Cai Y, Wei Z, Song C, Tang C, Han W, Dong X, 2019
  • Antitumor effect of a Pt-loaded nanocomposite based on graphene quantum dots combats hypoxia-induced chemoresistance of oral squamous cell carcinoma, Wei Z, Yin X, Cai Y, Xu W, Song C, Wang Y, Zhang J, Kang A, Wang Z, Han W, 2018
Nano Drug Delivery Tumor Microenvironment Oral Cancer Hypoxia Nanotechnology Targeted Therapy Cancer Research Biomedical Engineering Drug Delivery Systems Oncology

Contact us

Let's talk!
* Required
* Required
* Required
* Invalid email address
By submitting this form, you agree that IoT ONE may contact you with insights and marketing messaging.
No thanks, I don't want to receive any marketing emails from IoT ONE.
Submit

Thank you for your message!
We will contact you soon.